The British Journal of Cardiology

This site is intended for UK healthcare professionals

 
BJC_tv_logo_white
Sign in

exclude-home

Hiding in plain sight – a case-based overview of amyloidosis

Experts from the National Amyloidosis Centre in London examine three case studies, specifically focusing upon the symptoms that first aroused suspicion, the diagnostic tests that confirmed the condition, and the treatment options available to these patients.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence.

Amyloidosis: a comprehensive guide for the cardiovascular team

A guide for all members of the cardiovascular and primary care teams on what to look for, and what to do if you suspect amyloidosis: signs and symptoms, diagnostic tests and studies, and the treatment options currently available.

Funding for this video has come from multiple pharmaceutical industry sponsors. Further details of each company’s involvement can be found on the video page.

Rapid up-titration of heart failure therapies: practice strategies for adopting a STRONG-HF pathway in the UK

Protected: Rapid up-titration of heart failure therapies: practice strategies for adopting a STRONG-HF pathway in the UK

Sponsored

Dr Rajiv Sankaranarayanan, Consultant Cardiologist, University Hospitals Liverpool is joined by Dr Parin Shah, Consultant Cardiologist, Swansea Bay University Health Board and Matthew Sunter, Lead Heart Failure Nurse, St. George's University Hospital, London as they share how they’ve implemented and adapted the STRONG-HF1 pathway to improve heart failure care. They discuss early patient identification, rapid optimisation, and collaborative follow-up models tailored to local needs. Through shared learning and teamwork across disciplines, each centre has refined its approach to deliver more efficient, patient-centred heart failure management.

MC-UK-01533 | December 2025

Referral and diagnosis of suspected cardiac amyloidosis

Referral and diagnosis of suspected cardiac amyloidosis

This Masterclass was developed in collaboration with the National Amyloidosis Centre, London UK

Assessment of a patient with suspected amyloidosis requires a careful diagnostic workup, including cardiac imaging to identify amyloid infiltration in heart tissue that could lead to diastolic dysfunction and heart failure. In this Masterclass, clinicians and scientists from the National Amyloidosis Centre describe the laboratory tests and imaging techniques used to make an accurate diagnosis.
Amyloidosis signs and symptoms – red flags for cardiologists

Signs and symptoms of amyloidosis – red flags for cardiologists

This Masterclass was developed in collaboration with the National Amyloidosis Centre, London UK

Effective treatment of cardiac amyloidosis is dependent on early diagnosis; it is therefore important that clinicians have a high index of suspicion for the condition in their patients. Dr Josephine Mansell from the National Amyloidosis Centre outlines the “red flag” signs and symptoms that cardiologists, nurses or other healthcare professionals may observe in their patients, and which should prompt consideration of referral for a full diagnostic workup.
 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.